See how this article has been cited at scite.ai
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
G. Bammer, Report and Recommendations of Stage 2 Feasibility Research into the Controlled Availability of Opioids (Canberra, National Centre for Epidemiology and Population Health, The Australian National University and Australian Institute of Criminology, 1995).
G. Bammer (Ed.), ‘Australian Drug Markets Research: What Are We Doing? Where Are We Going? What Are The Gaps?’, Proceedings of a One-day Workshop Held at the Scarth Room, University House, ANU, 22 February 1993; Feasibility Research into the Controlled Availability of Opioids: Stage 2, Working Paper Number 2 (Canberra, National Centre for Epidemiology and Population Health, The Australian National University and Australian Institute of Criminology, 1993).
Y. Wadsworth, ‘What is Participatory Action Research?’, Paper produced by the Action Research Issues Association (Inc), 1993a; Y. Wadsworth, ‘How Can Professionals Help … Groups Do Their Own Participatory Action Research?’, Paper produced by the Action Research Issues Association (Inc), 1993b; R. McTaggart, ‘Principles for Participatory Action Research’, Paper Presented to the 3er Encuentro Mundial Investigation Participativa (The Third World Encounter on Participatory Research), Managua, Nicaragua, 3–9 September 1989. Reprinted in Wadsworth, 1991 (see Ref. 4).
Y. Wadsworth, Everyday Evaluation on the Run (Melbourne, Action Research Issues Association Inc., 1991).
M. Emery, Searching:—For New Directions—In New Ways—For New Times, Occasional Papers in Continuing Education, No. 12 (Canberra, Centre for Continuing Education, The Australian National University, 1982).
E. G. Guba & Y. S. Lincoln, Fourth Generation Evaluation (Newbury Park, Sage, 1989).
J. Norberry, ‘Legal Issues’, in: National Centre for Epidemiology and Population Health, Feasibility Research Into the Controlled Availability of Opioids: Volume 2, Background Papers (Canberra, National Centre for Epidemiology and Population Health, The Australian National University, 1991), pp. 87–115.
G. Bammer, J. Rainforth & B. Sibthorpe, ‘Possible Options for a Trial’, in: National Centre For Epidemiology and Population Health, Feasibility Research into the Controlled Availability of Opioids: Volume 2, Background Papers (Canberra, National Centre for Epidemiology and Population Health, The Australian National University, 1991a), pp. 117–176.
R. L. Hartnoll, M. C. Mitcheson, A. Battersby, G. Brown, M. Ellis, P. Fleming & N. Hedley, ‘Evaluation of Heroin Maintenance in Controlled Trial’, Archives of General Psychiatry, 37, 1980, pp. 877–884.
N. Hartland, ‘The Political Context’, in: National Centre for Epidemiology and Population Health, Feasibility Research Into the Controlled Availability of Opioids: Volume 2, Background Papers (Canberra, National Centre for Epidemiology and Population Health, The Australian National University, 1991), pp. 53–82; N. Hartland, D. McDonald, P. Dance & G. Bammer, Australian Reports into Drug Use and the Possibility of Heroin Maintenance’, Drug and Alcohol Review, 11, 1992, pp. 175–182.
R. Ostini & G. Bammer, ‘Ethical issues’, in: National Centre for Epidemiology and Population Health, Feasibility Research into the Controlled Availability of Opioids: Volume 2, Background Papers (Canberra, National Centre for Epidemiology and Population Health, The Australian National University, 1991), pp. 177–186; R. Ostini, G. Bammer, P. Dance & R. Goodin, ‘The Ethics of Experimental Heroin Maintenance’, Journal of Medical Ethics, 19, 1993, pp. 175–182.
G. Bammer, R. M. Douglas & P. Dance, ‘Evaluation by a Randomised Controlled Trial’, in: National Centre for Epidemiology and Population Health, Feasibility Research into the Controlled Availability of Opioids: Volume 2, Background Papers (Canberra, National Centre for Epidemiology and Population Health, The Australian National University, 1991b), pp. 279–286.
Hartnoll et al., op. cit., Ref. 9.
R. G. Jarrett & P.J. Solomon, ‘An Evaluation of Possible Designs for a Heroin Trial’ (draft), in: National Centre for Epidemiology and Population Health and Australian Institute of Criminology, Issues for Designing and Evaluating a ‘Heroin Trial’. Three Discussion Papers. Feasibility Research into the Controlled Availability of Opioids: Stage 2, Working Papers Number 8 (Canberra, National Centre for Epidemiology and Population Health, The Australian National University and Australian Institute of Criminology, 1994), pp. 11–30.
National Centre for Epidemiology and Population Health and Australian Institute of Criminology, Issues for Designing and Evaluating a ‘Heroin Trial’. Three Discussion Papers. Feasibility Research into the Controlled Availability of Opioids: Stage 2, Working Papers Number 8 (Canberra, National Centre for Epidemiology and Population Health, The Australian National University and Australian Institute of Criminology, 1994).
Bammer, op. cit., Ref. 1.
Hartnoll et al., op. cit, Ref. 9.
Jarret & Solomon, op. cit, Ref. 14.
J. Ward, R. P. Mattick & W. Hall, Key Issues in Methadone Maintenance Treatment (Kensington, University of New South Wales Press, 1992).
D. Crawford & G. Bammer, ‘Attitudes to a Trial’, in: National Centre for Epidemiology and Population Health, Feasibility Research into the Controlled Availability of Opioids: Volume 2, Background Papers (Canberra, National Centre for Epidemiology and Population Health, The Australian National University, 1991), pp. 187–278; G. Bammer, A. Stevens, P. Dance, R. Ostini & D. Crawford, ‘Controlled Heroin Availability in Australia? How and to What End?’, International Journal of the Addictions, 30, 1995, pp. 991–1007.
A. Uchtenhagen, A. Dobler-Mikola & F. Gutzwiller, ‘Medically Controlled Prescription of Narcotics: Fundamentals, Research Plan, First Experiences’, in: M. Rihs-Middel, D. C. Lewis, J. Clerc, C. Gear & D. Langenick-Cartwright (Eds.), The Medical Prescription of Narcotics: Scientific Foundations and Practical Experiences (Fribourg, Huber Verlag, in press).
Bammer et al., op. cit., Ref. 8.
Uchtenhagen et al., op. cit, Ref. 21.
Bammer, op. cit., Ref. 1.
Crawford & Bammer, op. cit., Ref. 20; Bammer et al., op. cit., Ref. 20.
G. Bammer, D. Tunnicliff & J. Chadwick-Masters, ‘How Could an Influx of Users be Prevented if Canberra Introduces a Trial of Controlled Availability of Heroin?’, Feasibility Research into the Controlled Availability of Opioids: Stage 2, Working Papers Number 9 (Canberra, National Centre for Epidemiology and Population Health, The Australian National University and Australian Institute of Criminology, 1994).
Bammer, op. cit, Ref. 1.
A. Larson, ‘Estimating the Numbers of Heroin Users in the ACT’, Feasibility Research into the Controlled Availability of Opioids: Stage 2, Working Paper Number 1 (Canberra, National Centre for Epidemiology and Population Health, The Australian National University and Australian Institute of Criminology, 1992); A. Larson & G. Bammer, ‘Why? Who? How? Estimating Numbers of Illicit Drug Users. Lessons From an ACT Case Study’, Australian Journal of Public Health, 20, 1996, pp. 495–501; A. Larson, A. Stevens & G. Wardlaw, ‘Indirect Estimates of ‘Hidden’ Populations: Capture—Recapture Methods to Estimate the Numbers of Heroin Users in die Australian Capital Territory’, Social Science and Medicine, 39, 1994, pp. 823–831.
G Humes, M. Moloney, F. Baas Becking & G. Bammer, ‘ “It will kill us faster than the White invasion”. Views on alcohol and other drug problems and HIV/AIDS risk in the Canberra/Queanbeyan Aboriginal community and on the suitability of a ‘heroin trial’ for Aboriginal heroin users’, Feasibility Research into the Controlled Availability of Opioids: Stage 2 Working Paper Number 6 (Canberra, Winnunga Nimmityjah, National Centre for Epidemiology and Population Health, The Australian National University and Australian Institute of Criminology, 1993); M. Moloney, G Humes, F. Baas Becking & G. Bammer, “Finding Out For Ourselves”. An analysis of the needs of ACT/Queanbeyan Aboriginal People, especially with regard to alcohol and other drug problems and HIV/AIDS risk (Canberra, Winnunga Nimmityjah, National Centre for Epidemiology and Population Health, The Australian National University and Australian Institute of Criminology, 1993).
Bammer, op. cit, Ref. 1.
Bammer, op. cit, Ref. 1.